NANOG and triple-negative breast carcinoma: In triple negative breast cancer (TNBC), a tumor with a previously described CSC population [30], we have demonstrated the enrichment of a CSC population, both in vitro and in vivo, using a NANOG-promoter driven GFP reporter system [25].